PCMA: Drug Manufacturer Price Hikes Offset by Rebates
December 20, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on reports that...
Filter by:
Press Releases
Filter by Year:Clear Filters- Press Releases
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHBP Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
- Value & Outcomes-Based Contracting
PCMA: Setting the Record Straight on the Pennsylvania Auditor General’s Medicaid Report
December 11, 2018
(Washington, D.C.) — The Pennsylvania Auditor General’s report on Medicaid and pharmacy benefit managers (PBMs) is undermined by failing to...
PCMA Statement on National Healthcare Expenditure Data Showing Lower Health Spending
December 07, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on new National Health...
PCMA Statement on the Administration’s Proposed Medicare Part D Rule
November 26, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement in response to the Administration’s...
PCMA Statement on the Administration’s Proposed Medicare Part B Pricing Model
October 25, 2018
Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on the Administration’s proposed Medicare Part B pricing model:...
PCMA Applauds the Administration for Enacting Legislation to Curb America’s Opioid Crisis
October 24, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) recognizes today’s enactment of historic legislation, the SUPPORT for Patients and Communities Act (H.R....
PCMA Statement on the Administration’s Proposal Requiring List Prices of Drugs in TV Ads
October 15, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Department...
October 10, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on President Trump signing into law S. 2553/...
PCMA Applauds Passage of Bill to Fight Opioid Epidemic
September 28, 2018
(Washington, D.C.) — Today, the U.S. House of Representatives passed the SUPPORT for Patients and Communities Act (H.R. 6), which will...
Labeed Diab of Humana Pharmacy Solutions Joins PCMA Board of Directors
September 25, 2018
Today, the Pharmaceutical Care Management Association (PCMA) welcomes Labeed Diab, RPh, President, Humana Pharmacy Solutions, as the newest member of the...
PCMA Names JC Scott New President and CEO
September 20, 2018
The Pharmaceutical Care Management Association (PCMA), the national trade association representing America’s pharmacy benefit managers, has named JC Scott the...
PCMA Statement on New Medicare Part D Formulary Design Flexibility
August 30, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association President and CEO Mark Merritt issued the following statement on the Administration’s announcement...